Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Human Molecular Genetics, 2003, Vol. 12, No. 17 DOI: 10.1093/hmg/ddg233 2221–2227 Expression of a truncated Sall1 transcriptional repressor is responsible for Townes–Brocks syndrome birth defects Susan McLeskey Kiefer1, Kevin K. Ohlemiller2, Jing Yang1, Bradley W. McDill1, Jürgen Kohlhase3 and Michael Rauchman1,* 1 Renal Division, School of Medicine, Washington University, St Louis and 2Central Institute for the Deaf, St Louis, MO 63110, USA and 3Institut für Humangenetik der Universität Göttingen, Gosslerstrasse 12d, D-37073 Göttingen, Germany Received May 19, 2003; Revised June 27, 2003; Accepted July 5, 2003 Townes–Brocks syndrome (TBS, OMIM #107480) is an autosomal dominant disorder that causes multiple birth defects including renal, ear, anal and limb malformations. Mutations in SALL1 have been postulated to cause TBS by haploinsufficiency; however, a mouse model carrying a sall1-null allele does not mimic the human syndrome. Since the mutations that cause TBS could express a truncated SALL1 protein containing the domain necessary for transcriptional repression but lacking the complete DNA binding domain, we hypothesized that TBS is due to dominant-negative or gain-of-function activity of a mutant protein. To test this hypothesis, we have created a mutant allele, sall1-DZn2-10, that produces a truncated protein and recapitulates the abnormalities found in human TBS. Heterozygous mice mimic TBS patients by displaying high-frequency sensorineural hearing loss, renal cystic hypoplasia and wrist bone abnormalities. Homozygous sall1-DZn2-10 mutant mice exhibit more severe defects than sall1-null mice including complete renal agenesis, exencephaly, limb and anal deformities. We demonstrate that truncated Sall1 mediates interaction with all Sall family members and could interfere with the normal function of all Sall proteins. These data support a model for the pathogenesis of TBS in which expression of a truncated SALL1 protein causes abnormal development of multiple organs. INTRODUCTION The role of transcriptional repression as an essential counterpart to gene activation has been recently recognized for many processes including embryonic development. The zinc finger transcription factor, Sall1, has been shown to repress gene expression (1,2) and play a key role in organogenesis (3). The Drosophila sall1 orthologues are critical for proper development of the fly eye, wing, trachea and antenna (4–7), and mutations in human SALL1 result in the developmental defects of the Townes–Brocks syndrome (TBS) (8). TBS patients exhibit malformed ears and hearing loss, imperforate anus, limb defects, and absent or hypoplastic kidneys. It has been postulated that TBS is due to haploinsufficiency of SALL1 (8,9); however, a null-allele of mouse sall1 does not mimic the human syndrome (3), suggesting the possibility of an alternative genetic mechanism. In support of this idea, mutations that cause TBS could result in production of a truncated protein encoding the N-terminus of SALL1, the region that we have shown mediates transcriptional repression (1). We thus postulated that expression of a truncated SALL1 protein is responsible for the developmental defects observed in TBS. In this report we describe a sall1 mutant allele, sall1DZn2-10, designed to mimic a mutation shown to cause TBS. This mutant expresses a truncated Sall1 protein and displays a striking recapitulation of TBS phenotypes. We further demonstrate that truncated Sall1 protein can mediate biochemical interactions with all wild-type Sall family members and thereby may interfere with their normal function. Together, these data provide genetic evidence supporting a dominantnegative or gain-of-function mechanism in the pathogenesis of TBS. *To whom correspondence should be addressed at: Department of Medicine and Biochemistry and Molecular Biology, Saint Louis University and Veterans Affairs Medical Center, Renal Division 657/111B-JC, 915 N Grand Avenue, St Louis, MO 63106, USA. Tel: þ1 3142896485; Email: [email protected] Human Molecular Genetics, Vol. 12, No. 17 # Oxford University Press 2003; all rights reserved 2222 Human Molecular Genetics, 2003, Vol. 12, No. 17 RESULTS Sall1 repression domain correlates with TBS mutations The mutations that cause TBS are clustered in the N-terminal third of the SALL1 coding region and could produce truncated proteins encoding only the N-terminus of SALL1, a domain that mediates transcriptional repression (1). Strikingly, the most N-terminal mutation that has been shown to cause TBS (9), 419delC (Fig. 1A), would encode a truncated protein consisting of the first 140 amino acids of human SALL1 that includes the 130 amino acid domain that is both necessary and sufficient for transcriptional repression by mouse Sall1 (Fig. 1B). When expressed as a fusion protein with a heterologous DNA binding domain (GAL4DB), the first 130 amino acids of mouse Sall1 and a longer 435 amino acid truncated protein were capable of repressing transcription over 100-fold from a GAL4DBresponsive luciferase reporter. Analogous constructs expressed as GST-fusion proteins interacted with a previously characterized (1) repression complex containing histone deacetylases (HDACs) (Fig. 1C). Removal of the first 130 amino acids abrogated both repression and interaction with the complex and mutation of the N-terminal C2HC zinc finger did not affect either. Because TBS mutations correlated with this important functional domain, we postulated that the pathogenesis of TBS is not due to haploinsufficiency of SALL1 and sought to test whether the expression of a Sall1 truncated protein could recapitulate TBS abnormalities in mice. Generation of sall1-DZn2-10 mice expressing truncated Sall1 protein To test this hypothesis, we generated mice carrying a targeted mutant allele (Fig. 2A), sall1-DZn2-10, to mimic one mutation shown to cause TBS (Fig. 1, 1277–1278delGA). After confirming each genotype by Southern blot (Fig. 2B), we analyzed embryonic lysates for the presence of Sall1 wild-type and truncated proteins (Fig. 2C). Western blotting with an N-terminal antibody revealed that a truncated protein of the expected size (Sall1-DZn2-10) was robustly expressed from the mutant allele (Fig. 2C) in all embryonic tissues affected in TBS patients (data not shown). Concomitant loss of expression of the wild-type Sall1 protein confirmed disruption of the sall1 locus by our targeting strategy. Thus, the sall1-DZn2-10 allele produces a truncated protein that has the potential to exert dominant-negative or gain-of-function effects during embryogenesis. Nishinakumura et al. (3) have shown that sall1-null mice (sall1/) are born at the expected Mendelian frequency and die soon after birth from renal failure. In contrast, no live homozygous sall1-DZn2-10 pups (sall1D/D) are born. The distribution of genotypes at embryonic day 14 to 16 (E14– E16) [60 sall1þ/þ (31%), 114 sall1þ/D (58%), 21 sall1D/D (11%)] showed that half of the sall1D/D embryos die during gestation prior to E14. Those that survived until E14 exhibited a variety of defects including renal agenesis (100%, Fig. 3B), exencephaly (38%, Fig. 3D), limb abnormalities (57%) including syndactlyly (Fig. 3F) or missing digits (Fig. 4G) and imperforate anus (>50%, Fig. 4C). Removal of Neo by crossing to b-actin cre transgenic mice had no effect on the phenotypes observed (data not shown). Because sall1-DZn2-10 mice exhibit more severe and multi-organ defects not seen in sall1-null mice, we next sought to investigate in more detail sall1-DZn2-10 heterozygous and homozygous mice for abnormalities that mimic TBS. sall1-DZn2-10 mice mimic TBS developmental defects Similar to 90% of TBS patients who are diagnosed with hearing loss (9), sall1þ/D mice were found to have a high frequency hearing loss when compared to wild-type littermates (Fig. 4A). Differences in thresholds for auditory evoked brain-stem responses were consistent with a high frequency sensorineural hearing deficit and a few individual mice also exhibited a mild conductive deficit (data not shown). This pattern of hearing loss is strikingly comparable to TBS patients who have been documented to have higher threshold responses at highfrequency with a small variable conductive component (10). sall1-DZn2-10 homozygous mice exhibit defects in formation of their anus. Over 50% of homozygous embryos exhibit the most serious TBS ano-rectal defect, imperforate anus (Fig. 4B and C). While wild-type embryos exhibited an evident external anal opening, the rectum of the mutant appeared to fuse with the urogenital system. Histologic sections (insets 1–3) of dissected bladder (b), urethra (u) and rectum (r) revealed that the mutant ano-rectal region fused with the urethra to form a common lumen for the urogenital and digestive systems. This type of ano-rectal malformation shares characteristics with hedgehog and Gli mutants (11). Since the Drosophila and Medaka sal genes have been shown to be activated by hedgehog signalling, overlapping anal phenotypes may reflect action of these molecules in a common signalling pathway (5,12). Heterozygous sall1-DZn2-10 mice exhibit a lethal, low penetrance (5%) gastrointestinal phenotype manifested as bowel obstruction at 3–6 weeks of age (data not shown). This abnormality may be the counterpart of a suspected bowel motility disorder manifested by severe constipation of some TBS patients (J. Kohlhase, unpublished data). The third birth defect that is most commonly observed in TBS patients is limb malformations. Skeletal staining revealed the absence of the triquetral bone in the wrist in all sall1þ/D adult limbs (Fig. 4D and E). The triquetrum, normally present on the dorsal side of the wrist (open arrowhead), was completely absent in all sall1þ/D mice. In its absence, the underlying pisiform (solid arrowhead) was fully visible from the dorsal aspect. In addition, the hamate (asterisk) did not adopt its characteristic triangular appearance to extend to the distal side of the 5th metacarpal. These abnormalities of the carpal bones are identical to those described in the original patient reports by Townes and Brocks (13). Additional skeletal abnormalities described for TBS patients were also seen in sall1D/D mutant embryos where 12 out of 21 (57%) exhibited gross limb abnormalities, including an absent first digit (Fig. 4G) or syndactyly of digits 2 and 3 (Fig. 3F) affecting one or more limbs. Skeletal staining revealed more severe wrist defects including the absence of multiple wrist bones, metacarpal hypoplasia and fusion (Fig. 4G, digits 4 and 5). Analogous defects described for the forelimbs were also found in the hindlimbs of sall1þ/D and sall1D/D mice (data not shown). Human Molecular Genetics, 2003, Vol. 12, No. 17 2223 Figure 1. Truncated proteins produced by TBS mutations would include the Sall1 transcriptional repression and HDAC interaction domains. (A) Schematic of the mouse Sall1 N-terminus with protein domains noted [C2HC-type zinc finger (oval), threonine-rich (substituted by a serine-rich domain in human SALL1), glutamine-rich, and serine-rich]. The length of the truncated protein produced by TBS mutations is indicated [a, 419delC (9); b, 817delG (27); c, 840delC (28); d, 826C > T (9); e, 1115C > A (8); f, 1146delT (9); g, 1200–1206del7 (9); h, 1277–1278delGA (9)]. (B) The first 130 amino acids domain of mouse Sall1 is necessary and sufficient for repression. GAL4DB-Sall1-N-terminal constructs were expressed in cells with a reporter in which luciferase gene transcription is under the control of five GAL4DB binding sites. Normalized luciferase activity of each construct was divided by the activity of cells transfected with GAL4DB alone to obtain fold repression. Values are plotted as the mean SD of triplicate transfection from two independent experiments. (C) The same 130 amino acid domain is necessary and sufficient for interaction with HDAC1 and 2. The Sall1-N constructs used for the repression assays were constructed as GST-fusions and overexpressed in cells. Glutathione pulldown experiments demonstrated an interaction with endogenous HDAC1 and 2 for only those contructs that exhibit repression activity. Approximately 60% of TBS patients with documented SALL1 mutations have been reported to have kidney defects, most commonly renal hypoplasia with or without cysts (9). These renal abnormalities are recapitulated in the sall1-DZn2-10 mouse because at least 25% of sall1þ/D mice were found to have hypoplastic, cystic kidneys (Fig. 4H and I). Numerous small and, on occasion, large cysts covered the kidney surface of some sall1þ/D adult mice and were never observed in wildtype littermates. These macroscopic cysts were confirmed by histology that revealed dilated renal tubules and mimicked documented renal abnormalities of TBS patients (14). We also observed isolated renal hypoplasia without cystic changes in both adult and embryonic sall1þ/D mice indicating that improper kidney development led to reduced kidney size (data not shown). Truncated Sall1 interacts with all Sall family members Comparison of the multi-organ defects of sall1-DZn2-10 mice and the exclusively renal phenotype of sall1-null mice suggests that the truncated Sall1 protein acts in a dominant-negative or gain-of-function fashion. Since Sall family members are co-expressed in many developing tissues and are thought to be functionally redundant (4,15), it has been suggested that the truncated Sall1 protein may interfere with the function of wild-type Sall proteins through direct interaction (1,16). In support of this mechanism, we found that the N-terminal protein expressed by sall1-DZn2-10 mice can bind specifically with all four Sall proteins, but not with an unrelated zinc finger transcriptional repressor, ZEB1 (Fig. 5). Full-length Sall1 also interacts with all wild-type Sall family proteins, suggesting that homo- and heteromeric complexes are an integral part of normal Sall function. Sall1 and Sall2 exhibit a genetic interaction in mutant mice (J. Kohlhase, unpublished data), substantiating the in vivo relevance of this functional interaction. These data support a model in which the Sall1 truncated protein could interfere with any wild-type Sall protein in a tissue where they are co-expressed. DISCUSSION Molecular genetic studies of congenital anomaly syndromes have shown that many are due to haploinsufficiency of transcription factors (17). For example, Renal Coloboma syndrome and Aniridia have been shown genetically to arise from haploinsufficiency of the paired box transcription factors PAX2 and PAX6 (18,19). SALL1 mutations have been suggested to cause TBS by the same paradigm, although a sall1-null mouse does not mimic the human syndrome. Recent in vitro studies have raised the possibility that expression of a truncated protein rather than haploinsufficiency causes TBS (1,16), and in this report we provide in vivo genetic evidence to confirm this hypothesis. Because the phenotypes of sall1-DZn2-10 mice are more severe than sall1-null mice and recapitulate the multiorgan abnormalities that define TBS, we conclude that this syndrome is caused by expression of a truncated Sall1 protein exerting severe effects on developing organs. Truncated Sall1 protein could act either in a dominantnegative or gain-of-function fashion. We show that truncated Sall1 protein produced by the sall1-DZn2-10 mutant allele can 2224 Human Molecular Genetics, 2003, Vol. 12, No. 17 Figure 2. sall1 gene disruption. (A) Schematic of the sall1 locus, the targeting vector and the sall1-DZn2-10 mutant allele (X, Xho1; H, HindIII). Zinc finger domains (white ovals) and clustered TBS mutations that could result in a truncated protein are indicated (bracket). The targeting vector introduced a stop codon (stop), LoxP sites (gray triangles) and a neomycin cassette (Neo) after this region. The probe and predicted HindIII restriction fragments for Southern analysis are shown. (B) Southern analysis of embryos from a sall1þ/D intercross by HindIII digestion of embryo tail DNA. (C) Western analysis of embryo limb lysates show loss of the wild-type protein and production of a truncated protein (Sall1-DZn2-10) from the mutant allele. interact with all Sall proteins and therefore has the potential to exert deleterious effects on all Sall functions in the cell (Fig. 5A). The glutamine-rich domain that has been shown to be critical for Sall1–Sall3 interaction (16) is present in the protein expressed by sall1-DZn2-10 mice, but would be absent in the shortest protein that could be expressed in a TBS patient (9). Preliminary studies suggest that this shorter protein can also interact with other Sall family members, albeit at much lower affinity (data not shown), but it remains to be elucidated if this level of interaction is physiologically relevant. Interaction of truncated Sall1 could prevent other Sall proteins from compensating for loss of wild-type Sall1 or interfere with their function in tissues where Sall proteins are co-expressed but subserve unique roles. An analogous paradigm where expression of a truncated protein disrupts development has been demonstrated for the zinc finger transcription factors Ikaros and Gli3 (20–22). Recently, it has been shown that Okihiro syndrome is also caused by truncating mutations in the SALL4 gene (23,24), implying a related mechanism. Interestingly, the phenotypic spectrum of TBS and Okihiro overlap, thus, we suggest that expression of a truncated SALL4 protein may exert similar activity to cause some of the same developmental defects in both syndromes. Previously, we have demonstrated that the N-terminus of Sall1 mediates transcriptional repression by recruitment of an HDAC-containing complex resembling NuRD (1). Here, we have further mapped this domain and show that the first 130 amino acids of Sall1 are necessary and sufficient to mediate repression (Fig. 1A). Based on the human SALL1 mutations reported to date (9), the shortest protein that could be expressed in TBS patients corresponds to this minimal repression domain. Therefore, we hypothesize that the truncated protein could be affecting repression of target genes. In sall1-DZn2-10 mice, the truncated protein is present in both the nucleus and cytoplasm (data not shown), however it lacks the zinc fingers thought to interact with DNA. The interaction of truncated Sall1 with full-length Sall proteins could provide a mechanism by which the truncated protein is brought to DNA to directly alter gene regulation. Alternatively, heterodimerization of truncated Sall1 with wild-type Sall family members could prevent normal Sall regulation of target genes by affecting cellular localization (16) or DNA binding. Finally, the ability of truncated Sall1 to interact with an HDAC-containing co-repressor complex (1) suggests the possibility of more widespread gain-of-function effects on gene expression by sequestering common co-factors, such as HDACs, that are utilized by many transcription factors. Analysis of sall1-DZn2-10 mice provides insight into the function of sall genes in organogenesis and may identify TBS defects that may be under-reported or unrecognized clinically. Human Molecular Genetics, 2003, Vol. 12, No. 17 2225 Figure 3. Phenotypes of sall1-DZn2-10 homozygous embryos. (A and B) Renal agenesis. Dissection of the bladder (b), gonads (g), kidneys (k) and adrenals (a) from E16 sall1þ/þ (A) and sall1D/D (B) embryos shows that 100% (n ¼ 21) of sall1D/D embryos lack kidneys. (C and D) Exencephaly. Thirty-eight percent of sall1D/D (D) E14–E16 embryos (n ¼ 8) develop a neural tube closure defect that is not present in sall1þ/þ (C) or sall1þ/ littermates. (E and F) Syndactyly. Forelimbs from E15 embryos show a normal appearance of the digits for sall1D/þ (E) limbs and fusion of digits 2 and 3 (arrowheads) for a sall1D/D (F) littermate. Fifty-seven percent of limbs from sall1D/D embryos (n ¼ 12) have a gross limb defect such as syndactyly or oligodactyly. For instance, bowel obstruction observed in some sall1þ/D mice (data not shown) suggests an intestinal motility disorder that is manifested as severe chronic constipation in some TBS patients (J. Kohlhase, unpublished data) and as Hirschsprung’s disease in Okihiro’s syndrome (25). The severe limb and CNS defects observed in sall1-DZn2-10 homozygous mutants highlight a previously unrecognized essential role of sall genes in formation of the carpel/tarsal elements and in neural tube closure. Consistent with our results implicating sall1 in neural tube defects, TBS patients have been recently identified with type I Arnold–Chiari malformation (J. Kohlhase, unpublished data). In addition to recapitulating the defects seen in TBS patients, anomalies seen in sall1DZn2-10 mice such as hearing loss, imperforate anus and hypoplastic kidneys, represent major human congenital malformations that occur sporadically. The sall1 mutant mouse described here is an ideal animal model to investigate the function of sall genes in these important developmental processes. In summary, these studies establish sall1-DZn2-10 mice as a strikingly faithful mouse model of TBS and provide new insights into the pathogenesis of this disorder. Further study of this mouse mutant will uncover additional roles of sall genes as critical developmental regulators, give insights into their mechanism of action individually and in combination, and will serve as a powerful tool to identify genes acting in a common pathway to control vertebrate organogenesis. Figure 4. Phenotypes of sall1-DZn2-10 mice mimic TBS abnormalities. (A) Hearing defects. Audiometric thresholds in decibel levels of sall1þ/D mice (open square) are higher (P < 0.001, 2-way ANOVA) than wild-type littermates (filled square) and suggest a high frequency sensorineural defect. (B and C) Anal defects. Normal appearance of sall1þ/þ and fusion of the urethra (u) with the rectum (r) for sall1D/D embryos (arrowheads). H&E stained sections (insets 1–3) confirm a recto-urethral fistula in the mutant. (D and E) Limb defects in sall1þ/D mice. Skeletal analysis of left forelimbs (dorsal view) reveal an absent triquetrum (open arrowhead, missing in E) and a misshapen hamate (*) in sall1þ/D mice. (F and G) Limb defects of sall1D/D mice. Skeletal staining of E16 limbs of wild type (F) and sall1D/D (G) embryos show that the mutant embryo exhibits several absent wrist bones, fusion of the 4th and 5th metacarpal bones and an absent thumb. (H and I) Kidney defects. Some sall1þ/D kidneys were cystic and hypoplastic and show dilated renal tubules. MATERIALS AND METHODS Plasmid construction Sall1 N-terminus (amino acids 2–435, Sall1-DZn2-10), mutated Zn (amino acids 2–435 with the C2HC zinc finger mutated to TSHC), N-(130–435), N-(1–130) and full-length Sall1 were 2226 Human Molecular Genetics, 2003, Vol. 12, No. 17 Disruption of sall1 Figure 5. Specific interaction of Sall1 with all Sall proteins. GST-fusion proteins representing the N-terminal Sall1 protein expressed in sall1-DZn2–10 mice (GST-Sall1-DZn2-10) and full-length Sall1 (GST-Sall1) were co-expressed in COS-1 cells with epitope-tagged Sall proteins or an unrelated zinc finger transcriptional repressor ZEB1. Pulldown experiments revealed that GSTSall1-DZn2–10 and GST-Sall1 were capable of binding all four Sall proteins but not ZEB1. GST alone did not bind. constructed as GAL4DB- and GST-fusion proteins. Sall3 and Sall4 were cloned based on published sequence information and Sall2 (T. Benjamin, Harvard) and ZEB1 (D. Dean, Washington University) were generously donated. The Sall2 sequence was modified to encode the exon 1 splice variant and all Sall sequences were modified with a C-terminal epitope tag. Repression assays Briefly, cells were transiently transfected with GAL4DB-Sall1 fusion plasmid, a GAL4DB-responsive luciferase reporter and a plasmid containing constitutively expressed beta galactosidase to normalize for transfection efficiency. After 48 h, the cells were assayed for luciferase activity exactly as described previously (1). The normalized luciferase activity of each GAL4DB-Sall1 construct was compared to the activity of cells transfected with GAL4DB alone to calculate fold repression. Each construct was transfected in triplicate wells and two independent assays were averaged. 129/SvJ-derived RW-4 embryonic stem cells were electroporated with a vector designed to substitute a stop codon and a floxed neomycin cassette for nucleotides 1300–3443 of the mouse sall1 cDNA within exon 2 of the sall1 locus. One homologous recombinant clone was used to establish chimeric founders that were mated to outbred mice to generate mice that carried the sall1-DZn2-10 allele in a mixed 129-SvJ/ICR outbred background. Wild-type and mutant alleles were detected by PCR genotyping and Southern blotting by established methods. Embryonic limb protein extracts were prepared using RIPA buffer containing inhibitors (1 mg/ml leupeptin, 2 mg/ml antipain, 10 mg/ml benzamidine, 1 mg/ml chymostatin, 1 mg/ml pepstatin, 24 mg/ml Pefabloc, 20 mM NaF and 2 mM sodium molybdate) and western blotted with an antibody directed against the N-terminus of Sall1 (1). All experiments were performed under the auspices of the Institutional Animal Studies Committee. Hearing tests Auditory evoked brain-stem responses were recorded in 5week-old F1 sall1þ/D mice anesthetized with IP injection of 80 mg/kg ketamine, 15 mg/kg xylazine. Platinum needle electrodes were inserted subcutaneously just behind the right ear (active), at the vertex (reference) and in the back (ground) and used to record bioelectric potentials in response to 5 ms tonebursts emanating from a speaker located 7 cm lateral to the right ear, concentric with the external auditory meatus. Stimuli were presented freefield and calibrated using a microphone placed where the pinna would normally be. Responses were filtered (0.1–10 kHz), digitized at 30 kHz, and averaged over 1000 stimulus presentations (20/s). The minimum sound pressure level required for a response (short-latency negative wave) was determined at 5, 10, 20, 28.3 and 40 kHz, using a 5 dB minimum step size. Seven sall1þ/D and seven sall1þ/þ mice were tested. Morphology analysis Tissues were photographed using a Nikon SMZ800 dissecting microscope. Skeletal staining was performed as described (26). Adult kidney and embryo anal regions were paraffin embedded, sectioned and analyzed by hematosylin/eosin staining. Interaction assays For HDAC interaction assays, the same constructs assayed for repression as GAL4DB fusion proteins were constructed as GST-Sall1 fusion proteins and overexpressed in COS-1 cells. After 48–72 h, cells were lysed, precipitated with glutathione sepharose and analyzed for the presence of endogenous HDAC1 and 2 by western blot using commercially available antibodies as described previously (1). For Sall–Sall interaction studies, GST, GST-Sall1-N (Sall1-DZn2-10) and GST-Sall1 were overexpressed with either epitope-tagged Sall1, Sall2, Sall3 or Sall4 in COS-1 cells. Lysates were analyzed for the presence of overexpressed epitope-tagged Sall proteins by western blot as above. ACKNOWLEDGEMENTS We thank the Washington University Cancer Center Embryonic Stem Cell core, Mouse Genetics core, and the Molecular Biology and Pharmacology Morphology core for invaluable assistance, and Raphael Kopan, Sandy McLeskey, David Ornitz, Heiko Peters, YiPing Chen and Jim Kiefer for critical reading of the manuscript. The authors wish to thank the following funding agencies for support: NIH Training Grant 5T32DK07126 (S.M.K.), Deutsche Forschungsgemeinschaft KO 1850/3-2 (J.K.) and Edward Mallinckrodt Foundation (K.K.O.). Human Molecular Genetics, 2003, Vol. 12, No. 17 REFERENCES 1. Kiefer, S.M., McDill, B.W., Yang, J. and Rauchman, M. (2002) Murine Sall1 represses transcription by recruiting a histone deacetylase complex. J. Biol. Chem., 277, 14869–14876. 2. Netzer, C., Rieger, L., Brero, A., Zhang, C.D., Hinzke, M., Kohlhase, J. and Bohlander, S.K. (2001) SALL1, the gene mutated in Townes–Brocks syndrome, encodes a transcriptional repressor which interacts with TRF1/PIN2 and localizes to pericentromeric heterochromatin. Hum. Mol. Genet., 10, 3017–3024. 3. Nishinakamura, R., Matsumoto, Y., Nakao, K., Nakamura, K., Sato, A., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Scully, S., Lacey, D.L. et al. (2001) Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development, 128, 3105–3115. 4. Mollereau, B., Dominguez, M., Webel, R., Colley, N.J., Keung, B., de Celis, J.F. and Desplan, C. (2001) Two-step process for photoreceptor formation in Drosophila. Nature, 412, 911–913. 5. de Celis, J.F., Barrio, R. and Kafatos, F.C. (1996) A gene complex acting downstream of dpp in Drosophila wing morphogenesis. Nature, 381, 421–424. 6. Franch-Marro, X. and Casanova, J. (2002) Spalt-induced specification of distinct dorsal and ventral domains is required for Drosophila tracheal patterning. Dev. Biol., 250, 374–382. 7. Dong, P.D., Dicks, J.S. and Panganiban, G. (2002) Distal-less and homothorax regulate multiple targets to pattern the Drosophila antenna. Development, 129, 1967–1974. 8. Kohlhase, J., Wischermann, A., Reichenbach, H., Froster, U. and Engel,W. (1998) Mutations in the SALL1 putative transcription factor gene cause Townes–Brocks syndrome. Nat. Genet., 18, 81–83. 9. Kohlhase, J., Taschner, P.E., Burfeind, P., Pasche, B., Newman, B., Blanck, C., Breuning, M.H., ten Kate, L.P., Maaswinkel-Mooy, P., Mitulla, B. et al. (1999) Molecular analysis of SALL1 mutations in Townes–Brocks syndrome. Am. J. Hum. Genet., 64, 435–445. 10. Rossmiller, D.R. and Pasic, T.R. (1994) Hearing loss in Townes–Brocks syndrome. Otolaryngol. Head Neck Surg., 111, 175–180. 11. Mo, R., Kim, J.H., Zhang, J., Chiang, C., Hui, C.C. and Kim, P.C. (2001) Anorectal malformations caused by defects in sonic hedgehog signaling. Am. J. Pathol., 159, 765–774. 12. Koster, R., Stick, R., Loosli, F. and Wittbrodt, J. (1997) Medaka spalt acts as a target gene of hedgehog signaling. Development, 124, 3147–3156. 13. Townes, P.L. and Brocks, E.R. (1972) Hereditary syndrome of imperforate anus with hand, foot, and ear anomalies. J. Pediatr., 81, 321–326. 14. Barakat, A.Y., Butler, M.G., Salter, J.E. and Fogo, A. (1988) Townes– Brocks Syndrome: report of three additional patients with previously undescribed renal and cardiac abnormalities. Dysmorphol. Clin. Genet., 2, 104–108. 2227 15. Milan, M., Perez, L. and Cohen, S.M. (2002) Short-range cell interactions and cell survival in the Drosophila wing. Dev. Cell, 2, 797–805. 16. Sweetman, D., Smith, T., Farrell, E.R., Chantry, A. and Munsterberg, A. (2002) The conserved glutamine rich region of chick csal1 and csal3 mediates protein interactions with other spalt family members— implications for Townes–Brocks syndrome. J. Biol. Chem., 278, 6560–6566. 17. Seidman, J.G. and Seidman, C. (2002) Transcription factor haploinsufficiency: when half a loaf is not enough. J. Clin. Invest., 109, 451–455. 18. Eccles, M.R., He, S., Legge, M., Kumar, R., Fox, J., Zhou, C., French, M. and Tsai, R.W. (2002) PAX genes in development and disease: the role of PAX2 in urogenital tract development. Int. J. Dev. Biol., 46, 535–544. 19. Glaser, T., Cai, J., Epstein, J., Walton, D.S., Jepeal, L. and Maas, R. (1985) In Wiggs, J.R. (ed.), Molecular Genetics of Eye Disease. John Wiley and Sons, New York, pp. 51–82. 20. Sun, L., Liu, A. and Georgopoulos, K. (1996) Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J., 15, 5358–5369. 21. Georgopoulos, K., Bigby, M., Wang, J.H., Molnar, A., Wu, P., Winandy, S., and Sharpe, A. (1994) The Ikaros gene is required for the development of all lymphoid lineages. Cell, 79, 143–156. 22. Bose, J., Grotewold, L. and Ruther, U. (2002) Pallister-Hall syndrome phenotype in mice mutant for Gli3. Hum. Mol. Genet., 11, 1129–1135. 23. Al Baradie, R., Yamada, K., St Hilaire, C., Chan, W.M., Andrews, C., McIntosh, N., Nakano, M., Martonyi, E.J., Raymond, W.R., Okumura, S. et al. (2002) Duane Radial Ray Syndrome (Okihiro Syndrome) Maps to 20q13 and Results from Mutations in SALL4, a New Member of the SAL Family. Am. J. Hum. Genet, 71, 1195–1199. 24. Kohlhase, J., Heinrich, M., Schubert, L., Liebers, M., Kispert, A., Laccone, F., Turnpenny, P., Winter, R.M. and Reardon, W. (2002) Okihiro syndrome is caused by SALL4 mutations. Hum. Mol. Genet, 11, 2979–2987. 25. Okihiro, M.M., Tasaki, T., Nakano, K.K. and Bennett, B.K. (1977) Duane syndrome and congenital upper-limb anomalies. A familial occurrence. Arch. Neurol., 34, 174–179. 26. Peters, H., Neubuser, A., Kratochwil, K. and Balling, R. (1998) Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities. Genes Dev., 12, 2735–2747. 27. Salerno, A., Kohlhase, J. and Kaplan, B.S. (2000) Townes–Brocks syndrome and renal dysplasia: a novel mutation in the SALL1 gene. Pediatr. Nephrol., 14, 25–28. 28. Blanck, C., Kohlhase, J., Engels, S., Burfeind, P., Engel, W., Bottani, A., Patel, M.S., Kroes, H.Y. and Cobben, J.M. (2000) Three novel SALL1 mutations extend the mutational spectrum in Townes–Brocks syndrome [letter]. J. Med. Genet., 37, 303–307.